2026 ICD-10-CM Diagnosis Code C88.40Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission
ICD-10-CM Codes›C00–D49›C81-C96›C88
- Billable — Valid for Submission
- Chronic Condition
C88.40 is a billable ICD-10-CM diagnosis code for extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 820 through 825, 840 through 842, 974 through 976. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Non-Hodgkin lymphoma.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Diffuse low grade B-cell lymphoma
- Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
- Malignant lymphoma of the eye region
- Mucosa-associated lymphoid tissue lymphoma of orbit
- Mucosa-associated lymphoid tissue lymphoma of stomach
- Mucosa-associated lymphoma
- Non-Hodgkin's lymphoma of stomach
- Orbital lymphoma
- Primary cutaneous B-cell lymphoma
- Primary cutaneous marginal zone B-cell lymphoma
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue MALT-lymphoma NOS
- Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue MALT-lymphoma with failed remission
- Lymphoma of bronchial-associated lymphoid tissue BALT-lymphoma NOS
- Lymphoma of bronchial-associated lymphoid tissue BALT-lymphoma not having achieved remission
- Lymphoma of bronchial-associated lymphoid tissue BALT-lymphoma with failed remission
- Lymphoma of skin-associated lymphoid tissue SALT-lymphoma NOS
- Lymphoma of skin-associated lymphoid tissue SALT-lymphoma not having achieved remission
- Lymphoma of skin-associated lymphoid tissue SALT-lymphoma with failed remission
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Code History & ChangesHistory
Replacement C88.40 replaces the following previously assigned code(s):
- C88.4 - Extrnod mrgnl zn B-cell lymph of mucosa-assoc lymphoid tiss
Questions About C88.40Overview
Is C88.40 a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C88.40 group to?
When extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission is the principal diagnosis on an inpatient stay, it groups to MS-DRG 820, 821, 822, 823, 824, 825, 840, 841, 842, 974, 975, 976, with relative weights from 0.8945 to 5.8648 depending on complications. Higher weights mean higher Medicare reimbursement.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
